ADMA BIOLOGICS, INC. — Director's Dealing 2012

Apr 6, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ADMA BIOLOGICS, INC. (NONE)
CIK: 0001368514
Period of Report: 2012-04-04

Reporting Person: ELMS STEVE (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-04-04	Stock Option	$9.60	A	13258	Acquired	2022-04-03	Common Stock (13258)	Direct

Footnotes

F1: 25% of these options will become exercisable on April 4, 2013, and the remainder will become exercisable in equal monthly installments on the 29th of each month until April 4, 2016.

F2: These stock options are held by Mr. Elms for the benefit of Aisling Capital LLC. Mr. Elms disclaims beneficial ownership of these securities and this report is not an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interest therein.